Relative ellipsoid zone reflectivity and its association with disease severity in age-related macular degeneration: a MACUSTAR study report

Research output: Contribution to journalJournal articleResearchpeer-review

Documents

  • Fulltext

    Final published version, 1.49 MB, PDF document

  • Marlene Saßmannshausen
  • Charlotte Behning
  • Ben Isselmann
  • Matthias Schmid
  • Robert P. Finger
  • F. G. Holz
  • Steffen Schmitz-Valckenberg
  • Maximilian Pfau
  • H. Agostini
  • L. Altay
  • R. Atia
  • F. Bandello
  • P. G. Basile
  • C. Behning
  • M. Belmouhand
  • M. Berger
  • A. Binns
  • C. J.F. Boon
  • M. Böttger
  • C. Bouchet
  • J. E. Brazier
  • T. Butt
  • C. Carapezzi
  • J. Carlton
  • A. Carneiro
  • A. Charil
  • R. Coimbra
  • M. Cozzi
  • D. P. Crabb
  • J. Cunha-Vaz
  • C. Dahlke
  • L. de Sisternes
  • H. Dunbar
  • R. P. Finger
  • E. Fletcher
  • H. Floyd
  • C. Francisco
  • M. Gutfleisch
  • R. Hogg
  • F. G. Holz
  • C. B. Hoyng
  • A. Kilani
  • J. Krätzschmar
  • L. Kühlewein
  • Larsen, Michael
  • S. Leal
  • Y. T.E. Lechanteur
  • U. F.O. Luhmann
  • A. Lüning
  • I. Marques
  • MACUSTAR Consortium

Quantification of the relative ellipsoid zone reflectivity (rEZR) might be a structural surrogate parameter for an early disease progression in the context of age-related macular degeneration (AMD). Within the European multicenter, cross-sectional MACUSTAR study, we have devised an automatic approach to determine the mean rEZR [arbitrary units, AU] at two independent visits in SD-OCT volume scans in study participants. Linear mixed-effects models were applied to analyze the association of AMD stage and AMD associated high-risk features including presence of pigmentary abnormalities, reticular pseudodrusen (RPD), volume of the retinal-pigment-epithelial–drusenoid-complex (RPEDC) with the rEZR. Intra-class correlation coefficients (ICC) were determined for rEZR reliability analysis. Within the overall study cohort (301 participants), we could observe decreased rEZR values (coefficient estimate ± standard error) of − 8.05 ± 2.44 AU (p = 0.0011) in the intermediate and of − 22.35 ± 3.28 AU (p < 0.0001) in the late AMD group. RPD presence was significantly associated with the rEZR in iAMD eyes (− 6.49 ± 3.14 AU; p = 0.0403), while there was a good ICC of 0.846 (95% confidence interval: 0.809; 0.876) in the overall study cohort. This study showed an association of rEZR with increasing disease severity and the presence of iAMD high-risk features. Further studies are necessary to evaluate the rEZR’s value as a novel biomarker for AMD and disease progression.

Original languageEnglish
Article number14933
JournalScientific Reports
Volume12
ISSN2045-2322
DOIs
Publication statusPublished - 2022

Bibliographical note

Publisher Copyright:
© 2022, The Author(s).

ID: 329292564